BankProv Announces Carol Houle and Joe Reilly As Co-CEOs
Provident Bancorp, Inc. (the "Company") (NASDAQ:PVBC), the holding company for BankProv (the "Bank"), announced today that its Board of Directors ("Board") has officially
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
Cannabis companies of all sizes are struggling to increase their profit margins and to make that happen, they're implementing different strategies. Lowering prices and premiumizing products are among the alternatives to create value. In addition, cannabis companies might look at risk mitigation as an alternative to achieve higher quality and prevent losses.
Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US
Israeli-based next-gen psychedelics biotech Clearmind Medicine (NASDAQ: CMND) together with partner clinical-stage pharma company SciSparc (NASDAQ: SPRC) has filed three provisional patent applications with the United S
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
Psychedelics biotech company Small Pharma Inc. (OTCQB: DMTTF) has dosed the first subject in its first-in-human clinical trial assessing proprietary DMT drug SPL028 paired with supportive therapy.
Salesforce Lays Out Harsher Policies Succumbing To Activist Pressure
Salesforce, Inc (NYSE: CRM) weighed new ways to cut costs as activist investors pressured the company.
Elon Musk Earlier on Wednesday, Speaking Virtually At World Government Summit In Dubai, Said Towards The End Of 2023 Would Be A Good Time To Find Someone Else To Run Twitter
-Reuters
https://www.reuters.com/technology/elon-musk-says-end-2023-good-timing-find-new-twitter-head-2023-02-15/
Electromed Announces Chief Executive Officer And President Retirement Of Kathleen Skarvan Effective date On Or Around July 1, 2023 And Succession Plan; Conducting A Comprehensive Search To Identify A New President And CEO And Engaged A National Executi…
Electromed, Inc. (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan will retire as President and Chief Executive Officer with a target effective date on or around
Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
Awakn Opens Fourth European Clinic, Norway Takes Center Stage
Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment
Cybin Inc. (NYSE: CYBN) has shared its unaudited financial results for the third quarter that ended Dec. 31, 2022.
The company held total cash of $16.9 (CA$22.5) million as of Dec. 31, 2022, and $15 million as of Feb. 14, 2023.